Cellectis SA
PAR:ALCLS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Cellectis SA
PAR:ALCLS
|
FR |
|
S
|
Shanghai Rightongene Biotechnology Co Ltd
SSE:688217
|
CN |
|
K
|
Ktbst Mixed Freehold and Leasehold Real Estate Investment Trust
SET:KTBSTMR
|
TH |
|
C
|
CoAsia Corp
KOSDAQ:045970
|
KR |
|
U
|
Ultimate Games SA
WSE:ULG
|
PL |
|
R
|
Reserve Petroleum Co
OTC:RSRV
|
US |
|
WEG SA
BOVESPA:WEGE3
|
BR |
|
A
|
Anhui Korrun Co Ltd
SZSE:300577
|
CN |
|
T
|
Topaz Energy Corp
TSX:TPZ
|
CA |
|
Legend Holdings Corp
HKEX:3396
|
CN |
Bankruptcy Probability
Cellectis SA's probability of bankruptcy is hidden . The solvency score is hidden .
We take all the information about a company's solvency (such as how easily a company can pay interest on its outstanding debt, how much cash it has, the amount of debt, and more) and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Cellectis SA Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| FR |
|
Cellectis SA
PAR:ALCLS
|
204.4m EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
370.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Exact Sciences Corp
NASDAQ:EXAS
|
355.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
188B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
166.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
110B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
78B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
69B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Cellectis SA's probability of bankruptcy is hidden .
The probability of bankruptcy is estimated using credit risk models that assess its financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Cellectis SA has total debt of 101.7m USD. This includes both short-term (0 USD) and long-term (101.7m USD) debt.
You can find a full breakdown on its Balance Sheet.
